Article

Soy May Help Improve Bone Cancer Treatment

Using a 3D model, investigators found a soy-based compound was effective in treating bone cancer.

Soy may help improve bone cancer treatment, according to a new study published in Acta Biomaterialia.

Osteosarcoma is a rare form of bone cancer that most often occurs in children and young adults and is the second leading cause of cancer death in children. Despite medical advances, those living with osteosarcoma and metastatic bone cancer have a high rate of recurrence.

Treatment for the disease involves a surgery to remove the tumor as well as pre- and postoperative chemotherapy. During surgery, large areas of bone need to be removed and repaired, causing patients to often experience significant amounts of inflammation during reconstruction.

Investigators at Washington State University (WSU) constructed a 3D-printed bone-like scaffold to determine whether soy-based chemical compounds could be used to shrink cancer tumors. The compounds were slowly released into samples containing bone cancer as well as healthy bone cells. Isoflavones, a plant-derived estrogen found in soybeans, have been found to impede cancer cell growth for many types of cancer without being toxic to normal cells.

One compound caused a 90% reduction in bone cancer cell viability in the samples after 11 days, whereas 2 other compounds improved the growth of healthy bone cells. The soy compounds also reduced inflammation, which could help improve overall recovery, according to the study.

"These results advance our understanding in providing therapeutic approaches in using synthetic bone grafts as a drug delivery vehicle," Susmita Bose, PhD, professor in WSU's School of Mechanical and Materials Engineering, said in a press release.

More research is needed, especially long-term studies using animal and other malignant cells, according to the study authors. Investigators hope to continue researching the benefits of integrating natural compounds in biomedical technology.

Reference:

Researchers use soy to improve bone cancer treatment [News Release] September 15; 2020. Pullman, Washington. https://www.sciencedaily.com/releases/2020/09/200915090132.htm. Accessed September 23, 2020.

Related Videos
Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia (CLL), with an emphasis on the pivotal role pharmacists play in supporting medication adherence and treatment decisions.
Image Credit: © alenamozhjer - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Image Credit: © Andrey Popov - stock.adobe.com
Image Credit: © peopleimages.com - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards